2024 - Kidney Research Impact Report - Flipbook - Page 5
Jindal Research Chair for the
Prevention of Kidney Disease
Dr. Edward Clark knows how devastating critical illness can be for
the kidneys. He specializes in caring for the 10% of patients in the
ICU whose kidneys stop working. Half do not survive, and one in
four survivors develop chronic kidney disease and need life-long
dialysis.
As The Ottawa Hospital’s new Jindal Chair for Kidney Disease
Prevention, Dr. Clark will be able to accelerate his research, which
aims to help more critically ill patients survive acute kidney injury and
recover enough kidney function to avoid dialysis.
Dr. Clark previously led a trailblazing pilot clinical trial that showed
that giving ICU patients intravenous albumin, rather than just saline,
reduces blood pressure drops during dialysis, a side e昀昀ect which
can lead to further kidney injury and other complications. The Chair
will allow Dr. Clark to launch a larger trial with 16 sites across
Canada to further test this approach, generating evidence that could
change how these patients are cared for.
“Ultimately, our goal is
to have more patients
leave the ICU without
the burden of chronic
kidney disease.”
DR. EDWARD CLARK
ASSOCIATE SCIENTIST & JINDAL CHAIR
FOR KIDNEY DISEASE PREVENTION
The Jindal Chair for Kidney Disease Prevention was established in 2013, thanks to the generous support of Dr. Shiv
L. Jindal and his wife Sharita, with the goal of supporting a wide range of research. The first chair-holder, Dr. Manish
Sood, has made important advances in “big data” research to improve prevention and treatment of kidney disease,
including the development of an online calculator anyone can use to predict their risk of developing chronic kidney
disease.
The Ottawa Hospital | Kidney Research Centre
5
